- Home
- AXSM vs STEP Comparison
AXSM vs STEP Comparison
Compare AXSM & STEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- STEP
- Stock Information
- Founded
- AXSM 2012
- STEP 2007
- Country
- AXSM United States
- STEP United States
- Employees
- AXSM N/A
- STEP N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- STEP Finance/Investors Services
- Sector
- AXSM Health Care
- STEP Finance
- Exchange
- AXSM Nasdaq
- STEP Nasdaq
- Market Cap
- AXSM 5.1B
- STEP 4.9B
- IPO Year
- AXSM 2015
- STEP 2020
- Fundamental
- Price
- AXSM $116.78
- STEP $60.80
- Analyst Decision
- AXSM Strong Buy
- STEP Buy
- Analyst Count
- AXSM 17
- STEP 7
- Target Price
- AXSM $175.76
- STEP $64.00
- AVG Volume (30 Days)
- AXSM 591.0K
- STEP 502.2K
- Earning Date
- AXSM 11-11-2025
- STEP 11-06-2025
- Dividend Yield
- AXSM N/A
- STEP 2.49%
- EPS Growth
- AXSM N/A
- STEP N/A
- EPS
- AXSM N/A
- STEP N/A
- Revenue
- AXSM $495,033,000.00
- STEP $1,352,716,000.00
- Revenue This Year
- AXSM $64.05
- STEP N/A
- Revenue Next Year
- AXSM $56.46
- STEP $19.84
- P/E Ratio
- AXSM N/A
- STEP N/A
- Revenue Growth
- AXSM 69.83
- STEP 87.87
- 52 Week Low
- AXSM $75.56
- STEP $40.07
- 52 Week High
- AXSM $139.13
- STEP $70.38
- Technical
- Relative Strength Index (RSI)
- AXSM 47.95
- STEP 49.36
- Support Level
- AXSM $123.54
- STEP $59.99
- Resistance Level
- AXSM $130.00
- STEP $63.55
- Average True Range (ATR)
- AXSM 3.66
- STEP 1.67
- MACD
- AXSM -0.95
- STEP -0.06
- Stochastic Oscillator
- AXSM 4.51
- STEP 38.48
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.